{"title":"编者按","authors":"Quill Kukla","doi":"10.1353/ken.2023.a917927","DOIUrl":null,"url":null,"abstract":"<span><span>In lieu of</span> an abstract, here is a brief excerpt of the content:</span>\n<p> <ul> <li><!-- html_title --> Editor’s Note <!-- /html_title --></li> <li> Quill Kukla, <em>Editor-in-Chief</em> </li> </ul> <p><strong>T</strong>his issue of the <em>Kennedy Institute of Ethics Journal</em> contains two essays and one dialogue, all of which concern ethical and epistemological issues that arise at the meeting point of our cognitive and mental lives and technology.</p> <p>In the first piece, two leading bioethicists with expertise in neurotechnology, James Giordano and Joseph J. Fins, discuss a wide range of complex problems surrounding people with disorders of consciousness that make their mental states opaque to observers. It is especially difficult to know how to respectfully care for and interact with such people, since we cannot directly communicate with them and our technological methods for discerning whether and how they are conscious are nascent and unreliable. People with these disorders challenge our norms for decision-making and patient care, including end of life care. It is easy for doctors, who may only sporadically have contact with people with these disorders, to be unaware of their consciousness altogether. Because caring for people with these sorts of consciousness disorders is typically technologically intense, such care also raises difficult questions concerning resource allocation. Giordano and Fins discuss these and a wide range of other issues in depth. Their discussion of how the tools of disability studies and disability rights advocacy can and should be applied when it comes to people with whom we cannot communicate is particularly powerful. As Fins points out, the important principle, “Nothing about us without us,” cannot be honored in the case of people whose voices and experiences we cannot discern; this slogan presupposes communicative abilities. Fins and Giordano challenge us to revisit our concepts of accessibility and inclusion in ways that might let them be adapted to the needs of people with consciousness disorders.</p> <p>Phoebe Friesen and Anna Swartz—in “The First Smart Pill: Digital Revolution or Last Gasp?”—offer a critical social history of Abilify MyCite, a version of the popular antipsychotic drug Abilify, which contains a small sensor that digitally tracks when patients take the medication, thereby enabling compliance information to be shared with health care professionals. Friesen and Swartz show in detail the ways in which the story <strong>[End Page ix]</strong> of this drug’s use and uptake were fundamentally shaped by marketing pressures and financial incentives. Even though we do not actually have good evidence that the drug provides benefits that normal Abilify does not provide, nor that it increases compliance, Abilify MyCite was marketed as a success story. Bioethicists who were paid consultants for Otsuka, the maker of the drug, offered shallow analyses that justified the drug’s existence, focusing primarily on compliance and safety while skimming over deep ethical issues concerning privacy, surveillance, and the targeting of minority populations. Friesen and Swartz conclude that “MyCite was merely another move made in order to capitalize on the enormous success of Abilify that was slipping away from an increasingly desperate company.” Their discussion provides a fascinating case study in the production of medical knowledge and the complex ways it is controlled and shaped by financial interests, as well as driven by an optimistic enthusiasm for technological fixes in the medical and bioethical communities.</p> <p>Finally, Zohar Lederman and Nancy Jecker—in their essay, “Social Robots to Fend Off Loneliness?”—take up the ethically and existentially fascinating question of when and whether robots can and should be used to mitigate human loneliness. As they point out, loneliness is an urgent public health concern, particularly among older people and other vulnerable groups, but it has received very little bioethical attention. They show that one cannot give a fine-grained answer to the question of what role robots might play in helping with loneliness unless one dives into the nature and varieties of loneliness. This is a deep philosophical project, and the essay argues that loneliness comes in different varieties, many of which essentially concern deficiencies in human-human interactions that serve a wide variety of purposes for us, only some of which can be fulfilled by nonhuman robots. Lederman and Jecker raise fascinating questions about whether deception is integral to the kind of help that robots can in fact offer for fending off loneliness, and whether that would in turn...</p> </p>","PeriodicalId":46167,"journal":{"name":"Kennedy Institute of Ethics Journal","volume":"1 1","pages":""},"PeriodicalIF":1.1000,"publicationDate":"2024-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Editor's Note\",\"authors\":\"Quill Kukla\",\"doi\":\"10.1353/ken.2023.a917927\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<span><span>In lieu of</span> an abstract, here is a brief excerpt of the content:</span>\\n<p> <ul> <li><!-- html_title --> Editor’s Note <!-- /html_title --></li> <li> Quill Kukla, <em>Editor-in-Chief</em> </li> </ul> <p><strong>T</strong>his issue of the <em>Kennedy Institute of Ethics Journal</em> contains two essays and one dialogue, all of which concern ethical and epistemological issues that arise at the meeting point of our cognitive and mental lives and technology.</p> <p>In the first piece, two leading bioethicists with expertise in neurotechnology, James Giordano and Joseph J. Fins, discuss a wide range of complex problems surrounding people with disorders of consciousness that make their mental states opaque to observers. It is especially difficult to know how to respectfully care for and interact with such people, since we cannot directly communicate with them and our technological methods for discerning whether and how they are conscious are nascent and unreliable. People with these disorders challenge our norms for decision-making and patient care, including end of life care. It is easy for doctors, who may only sporadically have contact with people with these disorders, to be unaware of their consciousness altogether. Because caring for people with these sorts of consciousness disorders is typically technologically intense, such care also raises difficult questions concerning resource allocation. Giordano and Fins discuss these and a wide range of other issues in depth. Their discussion of how the tools of disability studies and disability rights advocacy can and should be applied when it comes to people with whom we cannot communicate is particularly powerful. As Fins points out, the important principle, “Nothing about us without us,” cannot be honored in the case of people whose voices and experiences we cannot discern; this slogan presupposes communicative abilities. Fins and Giordano challenge us to revisit our concepts of accessibility and inclusion in ways that might let them be adapted to the needs of people with consciousness disorders.</p> <p>Phoebe Friesen and Anna Swartz—in “The First Smart Pill: Digital Revolution or Last Gasp?”—offer a critical social history of Abilify MyCite, a version of the popular antipsychotic drug Abilify, which contains a small sensor that digitally tracks when patients take the medication, thereby enabling compliance information to be shared with health care professionals. Friesen and Swartz show in detail the ways in which the story <strong>[End Page ix]</strong> of this drug’s use and uptake were fundamentally shaped by marketing pressures and financial incentives. Even though we do not actually have good evidence that the drug provides benefits that normal Abilify does not provide, nor that it increases compliance, Abilify MyCite was marketed as a success story. Bioethicists who were paid consultants for Otsuka, the maker of the drug, offered shallow analyses that justified the drug’s existence, focusing primarily on compliance and safety while skimming over deep ethical issues concerning privacy, surveillance, and the targeting of minority populations. Friesen and Swartz conclude that “MyCite was merely another move made in order to capitalize on the enormous success of Abilify that was slipping away from an increasingly desperate company.” Their discussion provides a fascinating case study in the production of medical knowledge and the complex ways it is controlled and shaped by financial interests, as well as driven by an optimistic enthusiasm for technological fixes in the medical and bioethical communities.</p> <p>Finally, Zohar Lederman and Nancy Jecker—in their essay, “Social Robots to Fend Off Loneliness?”—take up the ethically and existentially fascinating question of when and whether robots can and should be used to mitigate human loneliness. As they point out, loneliness is an urgent public health concern, particularly among older people and other vulnerable groups, but it has received very little bioethical attention. They show that one cannot give a fine-grained answer to the question of what role robots might play in helping with loneliness unless one dives into the nature and varieties of loneliness. This is a deep philosophical project, and the essay argues that loneliness comes in different varieties, many of which essentially concern deficiencies in human-human interactions that serve a wide variety of purposes for us, only some of which can be fulfilled by nonhuman robots. Lederman and Jecker raise fascinating questions about whether deception is integral to the kind of help that robots can in fact offer for fending off loneliness, and whether that would in turn...</p> </p>\",\"PeriodicalId\":46167,\"journal\":{\"name\":\"Kennedy Institute of Ethics Journal\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2024-01-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kennedy Institute of Ethics Journal\",\"FirstCategoryId\":\"98\",\"ListUrlMain\":\"https://doi.org/10.1353/ken.2023.a917927\",\"RegionNum\":4,\"RegionCategory\":\"哲学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ETHICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kennedy Institute of Ethics Journal","FirstCategoryId":"98","ListUrlMain":"https://doi.org/10.1353/ken.2023.a917927","RegionNum":4,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ETHICS","Score":null,"Total":0}
引用次数: 0
摘要
以下是内容的简要摘录,以代替摘要: 编者按 奎尔-库克拉(Quill Kukla),主编 本期《肯尼迪伦理学研究所期刊》收录了两篇论文和一篇对话,均涉及在我们的认知和精神生活与技术的交汇点上出现的伦理学和认识论问题。在第一篇文章中,两位精通神经技术的顶尖生物伦理学家詹姆斯-焦尔达诺(James Giordano)和约瑟夫-J-芬斯(Joseph J. Fins)讨论了围绕意识障碍患者的一系列复杂问题,这些患者的精神状态对观察者来说是不透明的。由于我们无法与这些人直接交流,而且我们用于辨别他们是否有意识以及如何有意识的技术方法还处于萌芽阶段,并不可靠,因此要知道如何以尊重的态度照顾这些人并与他们互动尤为困难。患有这些疾病的人对我们的决策和病人护理(包括临终护理)规范提出了挑战。医生可能只是偶尔接触到这些失调症患者,很容易完全不了解他们的意识。由于对这类意识障碍患者的护理通常需要大量的技术,因此这类护理也提出了有关资源分配的难题。Giordano 和 Fins 深入讨论了这些问题以及其他一系列问题。他们对残疾研究和残疾人权利倡导的工具在涉及到无法与我们交流的人时如何应用以及应该如何应用的讨论尤为有力。正如芬斯指出的那样,"没有我们,就没有我们 "这一重要原则在我们无法辨别其声音和经历的情况下是无法兑现的;这一口号的前提是沟通能力。芬斯和乔尔达诺要求我们重新审视无障碍和全纳的概念,使其适应意识障碍者的需求。菲比-弗里森(Phoebe Friesen)和安娜-斯沃茨(Anna Swartz)--"第一颗智能药丸:提供了关于阿比利费 MyCite 的重要社会历史。阿比利费 MyCite 是一种流行的抗精神病药物,它含有一个小型传感器,能够以数字方式跟踪患者服药的时间,从而能够与医护人员共享遵医嘱信息。弗里森和斯沃茨详细介绍了营销压力和经济激励如何从根本上影响了这种药物的使用和吸收。尽管我们实际上并没有充分的证据证明这种药物能提供普通阿利福所不能提供的益处,也没有证据证明它能提高依从性,但阿利福 MyCite 却被当作一个成功的故事进行营销。为该药制造商大冢制药(Otsuka)提供有偿顾问服务的生命伦理学专家提供了肤浅的分析,证明该药的存在是合理的,他们主要关注的是依从性和安全性,而对有关隐私、监控和针对少数群体的深层伦理问题则一笔带过。弗里森和斯沃茨得出结论:"MyCite 不过是为了利用阿利费的巨大成功而采取的又一举措,而阿利费正在从一家日益绝望的公司手中溜走。他们的讨论提供了一个引人入胜的案例研究,说明了医学知识的生产及其被经济利益控制和塑造的复杂方式,以及医学界和生物伦理学界对技术修复的乐观热情。最后,佐哈尔-莱德曼(Zohar Lederman)和南希-杰克尔(Nancy Jecker)在他们的文章《社交机器人能抵御孤独吗》(Social Robots to Fend Off Loneliness?正如他们所指出的,孤独是一个紧迫的公共健康问题,尤其是在老年人和其他弱势群体中,但却很少受到生命伦理学的关注。他们指出,如果不深入研究孤独的本质和种类,就无法对机器人在帮助解决孤独问题方面可以发挥什么作用这一问题给出精细的答案。这是一个深奥的哲学课题,文章认为,孤独有不同的种类,其中许多主要涉及人与人之间互动的缺陷,而这种互动对我们来说有各种各样的目的,其中只有一部分可以由非人类机器人来实现。莱德曼和杰克尔提出了一个引人入胜的问题:欺骗是否是机器人为抵御孤独所能提供的帮助中不可或缺的一部分?
In lieu of an abstract, here is a brief excerpt of the content:
Editor’s Note
Quill Kukla, Editor-in-Chief
This issue of the Kennedy Institute of Ethics Journal contains two essays and one dialogue, all of which concern ethical and epistemological issues that arise at the meeting point of our cognitive and mental lives and technology.
In the first piece, two leading bioethicists with expertise in neurotechnology, James Giordano and Joseph J. Fins, discuss a wide range of complex problems surrounding people with disorders of consciousness that make their mental states opaque to observers. It is especially difficult to know how to respectfully care for and interact with such people, since we cannot directly communicate with them and our technological methods for discerning whether and how they are conscious are nascent and unreliable. People with these disorders challenge our norms for decision-making and patient care, including end of life care. It is easy for doctors, who may only sporadically have contact with people with these disorders, to be unaware of their consciousness altogether. Because caring for people with these sorts of consciousness disorders is typically technologically intense, such care also raises difficult questions concerning resource allocation. Giordano and Fins discuss these and a wide range of other issues in depth. Their discussion of how the tools of disability studies and disability rights advocacy can and should be applied when it comes to people with whom we cannot communicate is particularly powerful. As Fins points out, the important principle, “Nothing about us without us,” cannot be honored in the case of people whose voices and experiences we cannot discern; this slogan presupposes communicative abilities. Fins and Giordano challenge us to revisit our concepts of accessibility and inclusion in ways that might let them be adapted to the needs of people with consciousness disorders.
Phoebe Friesen and Anna Swartz—in “The First Smart Pill: Digital Revolution or Last Gasp?”—offer a critical social history of Abilify MyCite, a version of the popular antipsychotic drug Abilify, which contains a small sensor that digitally tracks when patients take the medication, thereby enabling compliance information to be shared with health care professionals. Friesen and Swartz show in detail the ways in which the story [End Page ix] of this drug’s use and uptake were fundamentally shaped by marketing pressures and financial incentives. Even though we do not actually have good evidence that the drug provides benefits that normal Abilify does not provide, nor that it increases compliance, Abilify MyCite was marketed as a success story. Bioethicists who were paid consultants for Otsuka, the maker of the drug, offered shallow analyses that justified the drug’s existence, focusing primarily on compliance and safety while skimming over deep ethical issues concerning privacy, surveillance, and the targeting of minority populations. Friesen and Swartz conclude that “MyCite was merely another move made in order to capitalize on the enormous success of Abilify that was slipping away from an increasingly desperate company.” Their discussion provides a fascinating case study in the production of medical knowledge and the complex ways it is controlled and shaped by financial interests, as well as driven by an optimistic enthusiasm for technological fixes in the medical and bioethical communities.
Finally, Zohar Lederman and Nancy Jecker—in their essay, “Social Robots to Fend Off Loneliness?”—take up the ethically and existentially fascinating question of when and whether robots can and should be used to mitigate human loneliness. As they point out, loneliness is an urgent public health concern, particularly among older people and other vulnerable groups, but it has received very little bioethical attention. They show that one cannot give a fine-grained answer to the question of what role robots might play in helping with loneliness unless one dives into the nature and varieties of loneliness. This is a deep philosophical project, and the essay argues that loneliness comes in different varieties, many of which essentially concern deficiencies in human-human interactions that serve a wide variety of purposes for us, only some of which can be fulfilled by nonhuman robots. Lederman and Jecker raise fascinating questions about whether deception is integral to the kind of help that robots can in fact offer for fending off loneliness, and whether that would in turn...
期刊介绍:
The Kennedy Institute of Ethics Journal offers a scholarly forum for diverse views on major issues in bioethics, such as analysis and critique of principlism, feminist perspectives in bioethics, the work of the Advisory Committee on Human Radiation Experiments, active euthanasia, genetics, health care reform, and organ transplantation. Each issue includes "Scope Notes," an overview and extensive annotated bibliography on a specific topic in bioethics, and "Bioethics Inside the Beltway," a report written by a Washington insider updating bioethics activities on the federal level.